- Antimicrobial resistance is a worldwide health threat due to the reduction of clinically effective antibiotics.
- Current drug discovery pipelines of new-in-class antibiotic agents are insufficient to offset the emergence of new AMR1.
- Innovative strategies to reduce the rate that AMR develops are thus critically needed.